+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Trintellix"

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 83 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Trintellix (formerly known as vortioxetine) is a prescription medication used to treat major depressive disorder (MDD) in adults. It is a serotonin modulator and stimulator (SMS) that works by increasing the amount of serotonin in the brain. Trintellix is a selective serotonin reuptake inhibitor (SSRI) and is used to treat depression, anxiety, and other mental health conditions. It is also used to treat obsessive-compulsive disorder (OCD) and post-traumatic stress disorder (PTSD). Trintellix is available in tablet form and is taken orally. Trintellix is manufactured by Takeda Pharmaceuticals and is marketed by Lundbeck. Other companies in the market include Pfizer, GlaxoSmithKline, and Eli Lilly. Show Less Read more